Cogent Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cogent Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cogent Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $21.1M, a 6.28% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $21.1M -$1.41M -6.28% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.5M -$1.59M -6.88% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $22M -$1.32M -5.65% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $22.2M -$1.64M -6.87% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $22.5M -$4.42M -16.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $23.1M +$19.9M +623% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $23.3M +$20.5M +741% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $23.8M +$20.6M +634% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $26.9M +$23.2M +624% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.2M -$972K -23.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.77M -$1.84M -40% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.25M -$1.8M -35.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.72M -$852K -18.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $4.17M -$760K -15.4% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $4.62M -$670K -12.7% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $5.05M -$588K -10.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $4.57M -$1.41M -23.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $4.93M -$1.39M -22% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $5.29M Dec 31, 2019 10-K 2021-03-16
Q3 2019 $5.63M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $5.98M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $6.32M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.